Bionoid Pharma, Inc.

$0.03-0.00%($-0.00)
TickerSpark Score
49/100
Weak
75
Valuation
60
Profitability
10
Growth
52
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BINP research report →

52-Week Range3% of range
Low $0.02
Current $0.03
High $0.45

Companybionoidinc.com

Bionoid Pharma, Inc. operates as a medical device company. It develops and markets innovative medical devices and technologies for the orthopedic and pain management markets.

CEO
Patricia Colvin
IPO
2007
Employees
5
HQ
Beverly Hills, CA, US

Price Chart

-90.26% · this period
$0.31$0.16$0.01Dec 20Jun 26Dec 29

Valuation

Market Cap
$1.62M
P/E
-8.29
P/S
-231.80
P/B
1.24
EV/EBITDA
10.76
Div Yield
0.00%

Profitability

Gross Margin
2210.54%
Op Margin
2707.59%
Net Margin
2795.37%
ROE
-14.90%
ROIC
-14.38%

Growth & Income

Revenue
$0 · -100.00%
Net Income
$-317,000 · -2803.62%
EPS
$-0.01 · -4900.00%
Op Income
$-276,571
FCF YoY
0.00%

Performance & Tape

52W High
$0.45
52W Low
$0.02
50D MA
$0.03
200D MA
$0.08
Beta
-4.66
Avg Volume
41.59K

Get TickerSpark's AI analysis on BINP

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our BINP Coverage

We haven't published any research on BINP yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate BINP Report →

Similar Companies